-
To seize the blue ocean of traditional Chinese medicine, traditional Chinese medicine pharmaceutical equipment needs to take the road of independent innovation
Time of Update: 2022-08-15
. In recent years, as domestic pharmaceutical machine companies continue to increase research and development and explore the road of innovation, they have gradually developed from a single product to a complete set of equipment, and from a single device to providing a complete set of technical solutions, providing a strong support for the high-quality development of traditional Chinese medicine enterprises.
-
The "14th Five-Year Plan" of drug supervision network security and information construction
Time of Update: 2022-08-15
5 key tasks, including promoting the integration and driving of regulatory data, consolidating the digital base for intelligent drug supervision, and consolidating the comprehensive security capability of network security The State Food and Drug Administration officially issued the "14th Five-Year Plan" (hereinafter referred to as the "Plan") for the construction of drug regulatory network security and informatization, which clearly proposes to upgrade the "two products and one machine" smart supervision capabilities and improve the integration of government services.
-
The pattern of traditional Chinese medicine is regenerated and changed!
Time of Update: 2022-08-15
China Resources' acquisition of Kunpharm not only changed the current pattern of the Chinese medicine industry, but also made it and Sinopharm two major state-owned enterprises further layout in the Chinese medicine sector, but also let the industry see that in the new cycle and new ecology of the development of the pharmaceutical industry, Certainty and potential in the development of the Chinese medicine industry .
-
The expansion of traditional Chinese medicine formula granules is imminent, and the top pharmaceutical companies are speeding up their deployment
Time of Update: 2022-08-15
Among them, according to the 2021 performance report data released by a number of pharmaceutical companies, the revenue of traditional Chinese medicine formula granules business has achieved year-on-year growth .
-
The importance of pharmaceutical equipment has become increasingly prominent under the frequent exposure to non-compliance of Chinese herbal decoction pieces
Time of Update: 2022-08-15
To better ensure the safety of Chinese herbal decoction pieces, and usher in more opportunities under the wave of standardization and high-quality development of the Chinese herbal decoction pieces industry In this regard, analysts believe that under the new situation and new requirements, traditional Chinese medicine enterprises need to reshape the growth logic and development path, such as using modern advanced digital technology and equipment to carry out digital transformation and upgrading to improve production quality and medication safety.
-
Traditional Chinese Medicine: In the medium and long term, it is recommended to focus on two main lines, and in the short term, focus on the targets with good performance in the interim report
Time of Update: 2022-08-15
The market is worth looking forward to Analysts pointed out that since last year, favorable policies for the traditional Chinese medicine industry have been gradually implemented, medical insurance payment has been tilted towards traditional Chinese medicine, and the industry policy margin has improved.
-
The demand for capacity expansion and efficiency enhancement of pharmaceutical companies continues to grow, and pharmaceutical equipment companies will usher in new opportunities for development
Time of Update: 2022-08-15
Trend, continue to meet the needs of pharmaceutical companies In this context, for pharmaceutical machine companies, if they want to seize the development opportunities, they must follow the industry closely by strengthening the research and development of intelligent products and moving towards a path of mechanical automation, unmanned operation, higher added value and more innovation.
-
In the past two weeks, these three pharmaceutical stocks have risen by more than 30%
Time of Update: 2022-08-15
. The 2021 annual report shows that the company achieved operating income of 342 million yuan, a year-on-year increase of 0.
81%, a trading volume of 38,200 lots, and a turnover of 121 million yuan As of the close on July 18, Nanxin Pharmaceutical closed at 32.
-
Focusing on the post-centralized procurement era, how should pharmaceutical companies respond?
Time of Update: 2022-08-15
power and market position For pharmaceutical companies, by exchanging price for volume, sales expenses can be greatly reduced, and the saved costs can be focused on the research and development of innovative drugs, first generic drugs, etc.
-
The pharmaceutical sector of Hong Kong stocks rose, BeiGene rose more than 11%, and many stocks rose more than 5%
Time of Update: 2022-08-15
4. 063 billion yuan The semi-annual report shows that in the first half of this year, the company achieved a total operating income of 4.
5 million, a 120% increase from the same period a year earlier In the second quarter alone, product revenue reached $304.
-
In the second half of the year, 8 blockbuster new anti-tumor drugs may be approved for marketing in China
Time of Update: 2022-08-15
. In the second half of the year, the indications of the 5 models that are expected to be approved for marketing involve non-small cell lung cancer, namely befotinib from Betta Pharmaceuticals, and the third-generation small molecule EGFR-TKI Rui from CSPC/Beida Pharmaceuticals.
-
Changes in the pharmaceutical sector: one share goes out of the second consecutive board, and there are multiple daily limits!
Time of Update: 2022-08-15
Its ophthalmology business has involved medical beauty business and has carried out ophthalmic plastic surgery items The main products and services of Guangzheng Ophthalmology include refractive items, cataract items, anterior segment items, posterior segment items, and optometry service items.
-
Since the beginning of 2022, 24 pharmaceutical stocks have risen by more than 20%
Time of Update: 2022-08-15
The stock is also a stock that has outperformed the broader market in the past month, with a cumulative turnover rate of over 30% in the past 5 days Xinhua Pharma: Range rose over 155% Xinhua Pharma's share price rose over 155% from January 4 to June 22.
-
The average salary of the 28 provinces has been released. Have the medical workers met the standard?
Time of Update: 2022-08-15
Although the salary of the company's executives has raised the average salary, from the perspective of business development, it can also be seen that its rapid business development has affected the salary of employees of the company Among them, the per capita annual salary of Rejing Bio is as high as 885,000 yuan.
-
Next week, Purui Ophthalmology and Fuyuan Pharmaceutical will subscribe for two new pharmaceutical shares
Time of Update: 2022-08-15
[Pharmaceutical Network Pharmaceutical Stock Market] The listing of new stocks has always attracted the attention of the industry. This week, a total of 11 new stocks were listed, including State Cab
-
The pharmaceutical industry has accelerated changes, and the demand for fully automated and intelligent robots may continue to expand
Time of Update: 2022-08-15
. The pharmaceutical industry is accelerating the change, and the demand for fully automated and intelligent robots may continue to expand (Source: Pharmaceutical Network) According to reports, in the intelligent workshop of a pharmaceutical company in Hebei, dozens of industrial robots replace traditional manual operations.
-
There are frequent changes in executives in the pharmaceutical industry, and there will be a wave of departures in the second half of the year
Time of Update: 2022-08-15
In In this context, it has become the norm for companies to adjust their development strategies and make active personnel adjustments In recent years, under the continuous promotion of the medical reform policy, the domestic pharmaceutical industry is undergoing earth-shaking changes.
-
The pharmaceutical sector is strong, and the approval of related ETF products is accelerating!
Time of Update: 2022-08-15
[Pharmaceutical Network Pharmaceutical Stock Market] In recent days, the pharmaceutical index has continued to rise, and the industry believes that the next sector index may still have a certain upwa
-
The product line is rich, and the home medical device industry is full of vitality
Time of Update: 2022-08-15
Rapid market growth and active domestic brands With the aging of the population, the improvement of testing and diagnosis and treatment technologies, and the development of data collection and chronic disease management services, the global home medical device market has shown a momentum of rapid development .
-
The development of the domestic innovative drug industry is accelerating, and the pharmaceutical machine industry is ushering in abundant development opportunities
Time of Update: 2022-08-15
. For example, at the end of last year, Canaan Technology stated on the investor interaction platform that the company's current business segment includes innovative pharmaceutical water equipment for biological preparations and pharmaceutical liquid dispensing system engineering business; in the future, the company will rely on pharmaceutical water equipment and pharmaceutical liquid dispensing system business.
